Structural Heart Disease: Explaining PFOs

GDMT Optimization for Heart Failure Patients

gdmt-optimization-for-heart-failure-patients [https://support.doctorpodcasting.com/media/k2/items/cache/397bc125f6cc474e368ea71ece38c185_S.jpg]https://support.doctorpodcasting.com/media/k2/items/cache/397bc125f6cc474e368ea71ece38c185_Generic.jpg Nationally recognized subject matter expert and leader in the field of transplant cardiology, Dr. Shelley Hall, will provide clinicians with an overview of guideline-directed medical therapy for heart failure patients who have reduced ejection fraction. This therapy is the cornerstone of pharmacological therapy for patients with heart failure but is under-utilized despite the multiple random trials demonstrating improved clinical outcomes. The different drug classes involved in GDMT will be discussed including the initial approach and effective titration in both inpatient and outpatient settings.

Understanding Microvascular Cardiovascular Disease

understanding-microvascular-cardiovascular-disease [https://support.doctorpodcasting.com/media/k2/items/cache/649d3f66b75674893b48016b45d3dd6c_S.jpg]https://support.doctorpodcasting.com/media/k2/items/cache/649d3f66b75674893b48016b45d3dd6c_Generic.jpg Dr. Kumar will explain coronary microvascular disease for clinicians. Up to 50% of people who experience chest pain, fatigue and shortness of breath symptoms may not have narrowing of arteries often caused by a build-up of plaque. These patients were often diagnosed with “chest pain syndrome X” until advances in specialized testing allowed cardiologists to provide a more specific diagnosis: coronary microvascular dysfunction (CMD). The podcast information will be helpful to primary care providers and others who may have patients experiencing the symptoms. Dr. Kumar is passionate about helping patients who experience these symptoms and their primary care physicians who may have challenges managing these patients. Together with a multidisciplinary team at Baylor Scott & White Heart and Vascular Hospital - Fort Worth, individualized treatment plans and options are provided. For more information about CMD and to make a referral, please reach out to a program nurse navigator at Baylor Scott & White Heart and Vascular Hospital - Fort Worth at 817.922.7132.

Cardiac CT for Primary Care

cardiac-ct-for-primary-care [https://support.doctorpodcasting.com/media/k2/items/cache/606dab5fc8d314b94b5c0f3624ac0664_S.jpg]https://support.doctorpodcasting.com/media/k2/items/cache/606dab5fc8d314b94b5c0f3624ac0664_Generic.jpg Cardiac CTs are being used more frequently to evaluate patients for coronary artery disease (CAD). This includes screening asymptomatic patients with coronary calcium scoring and the use of CT coronary angiography to evaluate for symptomatic coronary plaque. This on-demand webinar by HeartSpeak Consult Live is presented by Jeffrey Schussler, MD, FACC, FSCAI, chief medical officer and an interventional cardiologist on the medical staff at Baylor Scott & White Heart and Vascular Hospital.

Mitral Valve Disease: Latest Diagnostics and Treatment Options

mitral-valve-disease-latest-diagnostics-and-treatment-options [https://support.doctorpodcasting.com/media/k2/items/cache/13c5bf386f5e4af1b7f5e95b72e048dd_S.jpg]https://support.doctorpodcasting.com/media/k2/items/cache/13c5bf386f5e4af1b7f5e95b72e048dd_Generic.jpg The Centers for Disease Control and Prevention (CDC) estimate about 2.5% of the US population, or 7.5 million Americans, are living with mitral valve disease. As the population ages, mitral valve disease may become more prevalent in a primary care or clinical cardiologist's practice. Listen to Dr. Yashasvi Chugh address what clinicians need to know for their patients they suspect need a mitral valve specialist.

Structural Heart Disease: Explaining PFOs

structural-heart-disease-explaining-pfos [https://support.doctorpodcasting.com/media/k2/items/cache/460afe6eca494a52ce6587956c504d26_S.jpg]https://support.doctorpodcasting.com/media/k2/items/cache/460afe6eca494a52ce6587956c504d26_Generic.jpg Learn from an interventional cardiologist with particular training and interest in structural heart disease about the increased risk for strokes and the treatment options available for patients diagnosed with a patent foramen ovale (PFO); commonly known as a "hole in the heart."